Cellipont Bioservices

Cellipont Bioservices is a contract development and manufacturing organization (CDMO) specializing in cell therapy development and manufacturing. The company operates a purpose-built cGMP manufacturing facility in The Woodlands, Texas, and provides tailored solutions across the full development lifecycle from process development to commercial manufacturing.

Service Offerings:

• Process development and analytical development
• Clinical and commercial manufacturing
• Quality control and quality assurance
• Cell banking (MCB, WCB) and feeder cell bank services

Modalities & Cell Types:

• CAR-T and TCR-T cell therapies
• Allogeneic cell therapies
• Autologous cell therapies
• iPSC-derived cell therapies
• Exosome manufacturing
• Dendritic cells (DCs), fibroblasts, NK cells, MSCs, HSCs, and TIL therapies
• Native and genetically modified cells

Capabilities: The company's team brings extensive expertise in translating processes from benchtop to bedside, with demonstrated in-house scientific and manufacturing capabilities supporting preclinical through late-phase commercialization. Cellipont has achieved significant manufacturing milestones, including the release of its 100th GMP batch approximately one year after initiating GMP operations.